Estimating the Effect of Aerobic Exercise Training on Novel Lipid Biomarkers: A Systematic Review and Multivariate Meta-Analysis of Randomized Controlled Trials
Open accessAbstract
Background: Aerobic exercise training (AET) prescribed as lipid management treatment positively affects the standard lipid profile and reduces cardiovascular disease (CVD) risk. Apolipoproteins, lipid and apolipoprotein ratios, and lipoprotein sub-fractions may more effectively predict CVD risk than the standard lipid profile but an AET response in these biomarkers has not been established. Objectives: We conducted a quantitative systematic review of randomised controlled trials (RCTs) to (1) determine the effects of AET on lipoprotein sub-fractions, apolipoproteins and relevant ratios; and (2) identify study or intervention covariates associated with change in these biomarkers. Methods: We searched PubMed, EMBASE, all Web of Science and EBSCO health and medical online databases from inception to 31 December 2021. We included published RCTs of adult humans with ≥ 10 per group of participants; an AET intervention duration ≥ 12 weeks of at least moderate intensity (> 40% maximum oxygen consumption); and reporting pre/post measurements. Non-sedentary subjects, or those with chronic disease other than Metabolic Syndrome factors, or pregnant/lactating, as well as trials testing diet/medications, or resistance/isometric/unconventional training interventions, were excluded. Results: Fifty-seven RCTs totalling 3194 participants were analysed. Multivariate meta-analysis showed AET significantly raised antiatherogenic apolipoproteins and lipoprotein sub-fractions (mmol/L mean difference (MD) 0.047 (95% confidence interval (CI) 0.011, 0.082), P = .01); lowered atherogenic apoliproteins and lipoprotein sub-fractions (mmol/L MD − 0.08 (95% CI − 0.161, 0.0003), P = .05); and improved atherogenic lipid ratios (MD − 0.201 (95% CI − 0.291, − 0.111), P < .0001). Multivariate meta-regression showed intervention variables contributed to change in lipid, sub-fraction, and apoliprotein ratios. Conclusion: Aerobic exercise training positively impacts atherogenic lipid and apolipoprotein ratios, alipoproteins, and lipoprotein sub-fractions; and antiatherogenic apolipoproteins and lipoprotein sub-fractions. Cardiovascular disease risk predicted by these biomarkers may be lowered when AET is prescribed as treatment or prevention. PROSPERO ID: CRD42020151925.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review and multivariate meta-analysis of 57 RCTs (3194 sedentary adults) found that aerobic exercise training (AET) of ≥12 weeks at >40% VO2MAX improved several novel lipid biomarkers, including raising antiatherogenic apolipoproteins/lipoprotein sub-fractions and reducing atherogenic lipid/apolipoprotein ratios. Exploratory meta-regression suggested AET volume was associated with improvement in these biomarkers.
Key findings
- AET significantly raised antiatherogenic Apo A1 + A2 + HDL2 + HDL3 mmol/L (MD 0.047, 95% CI 0.011–0.082, P=0.01) and Apo A1 + A2 mg/dL (MD 2.297, 95% CI 0.441–4.153, P<0.02).
- AET significantly improved the joined atherogenic ratio TC/HDL-C + LDL-C/HDL-C + Apo B100/Apo A1 (MD −0.201, 95% CI −0.291 to −0.111, P<0.001).
- Joined atherogenic Apo B100 + VLDL mmol/L was not significant in the main model (MD −0.053, 95% CI −0.114 to 0.008, P=0.087), but became significant in the TESTEX ≥10 subanalysis (MD −0.08, 95% CI −0.161 to 0.000, P=0.05); Apo B100 mg/dL alone was not significant (MD −0.953, 95% CI −2.616 to 0.710, P=0.261).
- Exploratory meta-regression associated AET volume (intensity, minutes/session, sessions/week, intervention duration) with improvement in the joined TC/HDL-C + LDL-C/HDL-C + Apo B100/Apo A1 ratio (τ²=0.0023, R²=0.84); publication year was minimally associated (τ²=0.0134, R²=0.07). The authors estimated that a 2.073 mg/dL decrease in ApoB100 could anticipate a 4.34% decrease in coronary heart disease.
Methods
- Systematic review with multivariate meta-analysis and meta-regression (PROSPERO CRD42020151925; PRISMA), searching PubMed, EMBASE, all Web of Science, and EBSCO health/medical databases from inception to 31 December 2021, plus hand searches.
- Included published RCTs of sedentary adults without chronic disease other than MetS factors, with ≥10 per group, AET ≥12 weeks at >40% VO2MAX versus non-exercising control, and pre/post apolipoprotein, lipoprotein sub-fraction, or ratio outcomes; excluded non-sedentary participants, chronic disease other than MetS, pregnancy/lactation, and diet/medication or resistance/isometric/unconventional training trials.
- Fifty-seven RCTs totalling 3194 participants (exercise 1721; control 1473) were analysed. Continuous random-effects multivariate meta-analysis in CMA joined correlated/non-independent outcomes by atherogenic potential, direction, and unit; unjoinable outcomes used univariate models. Analyses included cumulative chronological pooling, TESTEX quality and risk-of-bias subanalyses, leave-one-out sensitivity, small-study tests, heterogeneity, and exploratory meta-regression with a priori intervention and study covariates.
Limitations
- Stated: aggregate RCT data rather than individual participant data (except one study); English-language search; exclusion of groups with N<10; few longer-duration RCTs; inclusion of lower-end moderate intensity (>40% VO2MAX) may understate effects; adherence/intensity reporting varied and some measures were subjective; a few control groups increased physical activity; meta-regression covariates were not randomised at study level, so findings are exploratory; imputed SDs/CIs/P values were conservative.
- Evident from the text: the main joined atherogenic Apo B100 + VLDL mmol/L result was not statistically significant (P=0.087) and reached significance only in the TESTEX ≥10 subanalysis; the abstract’s P=.05 for lowered atherogenic apolipoproteins/sub-fractions corresponds to that subanalysis rather than the main model. Meta-regression for the antiatherogenic Apo A1 + A2 + HDL2 + HDL3 mmol/L outcome alluded to overfitting.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
28 of 60 cited sources checked · 6 supported · 0 flagged · accuracy not yet measured
- Premisecitation
A priori aerobic exercise training intervention covariates (intensity, frequency, session duration and intervention duration) have been shown to influence lipid outcomes.
“A priori AET intervention covariates (intensity, frequency, session duration and intervention duration) that have been shown to influence lipid outcomes were analysed [19, 45, 46].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [19] Fikenzer K, Fikenzer S, Laufs U, Werner C. Effects of endurance training on serum lipids. Vasc Pharmacol. 2018;101:9–20. https://doi.org/10.1016/j.vph.2017.11.005. source
- cites [45] Hespanhol Junior LC, Pillay JD, van Mechelen W, Verhagen E. Meta-analyses of the effects of habitual running on indices of health in physically inactive adults. Sports Med. 2015;45(10):1455–68. https://doi.org/10.1007/s40279-015-0359-y. source
The Results section (Blood Serum Concentration Outcomes; page not provided) reports changes in triglycerides and HDL cholesterol after one year of running, supporting a connection between intervention duration and lipid outcomes. But the Dose-Response Analysis (page not provided) does not report that intensity, frequency, or session duration influenced lipid outcomes; its reported significant associations concern body mass and VO2max. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [46] Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. JAMA Intern Med. 2007;167(10):999–1008. https://doi.org/10.1001/archinte.167.10.999. source
- Premisecitation
Apolipoproteins and the Apo B100/Apo A1 ratio have been investigated as biomarkers more sensitive to identifying cardiovascular disease risk than total cholesterol, triglycerides and LDL-C.
“Apolipoproteins and the Apo B100/Apo A1 ratio have been investigated as biomarkers more senstive to identifying CVD risk than TC, TRG and LDL-C [9–11].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [9] Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein b in the prediction of coronary heart disease in men. Circulation. 2005;112(22):3375–83. https://doi.org/10.1161/CIRCULATIONAHA.104.532499. source
The Results and Discussion report that apoB was more strongly associated with coronary heart disease risk than LDL-C and triglycerides in the men studied. The paper measured apoB100 but did not evaluate the Apo B100/Apo A1 ratio; it says only that lipid ratios may improve prediction. The ratio-specific part of the claim is therefore not supported by this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [10] Chan DC, Watts GF. Apolipoproteins as markers and managers of coronary risk. QJM Int J Med. 2006;99(5):277–87. https://doi.org/10.1093/qjmed/hcl027. source
- cites [11] Wang F, Wang X, Ye P, Cao R, Zhang Y, Qi Y, et al. High-density lipoprotein 3 cholesterol is a predictive factor for arterial stiffness: a community-based 4.8-year prospective study. Lipids Health Dis. 2018;17(1):5. https://doi.org/10.1186/s12944-017-0650-z. source
The Background and Discussion discuss HDL subfractions and mention apoA1, but neither addresses the Apo B100/Apo A1 ratio or compares apolipoproteins with total cholesterol, triglycerides, and LDL-C for identifying CVD risk. Searches for that ratio and the claimed comparison found no supporting passage in our copy; page numbers were not provided. (LLM, conf=0.75)
Experimental — accuracy not yet measured
- Premisecitation
Trials reporting the effects of exercise on apolipoproteins and lipid ratios suggest that exercise training exerts a positive effect on these biomarkers.
“Trials reporting the effects of exercise on apolipoproteins and lipid ratios suggest that exercise training exerts a positive effect on these biomarkers [23–25]”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [23] Yazdani R, Marefati H, Shahesmaeili A, Nakhaei S, Bagheri A, Dastoorpoor M. Effect of aerobic exercises on serum levels of apolipoprotein A1 and apolipoprotein B, and their ratio in patients with chronic obstructive pulmonary disease. Tanaffos. 2018;17(2):82–9.
- cites [24] Edwards M, Loprinzi P. The dose–response association between reported moderate to vigorous intensity physical activity and atherogenic index of plasma: NHANES, 1999–2006. J Phys Act Health. 2019;16(5):368–70. https://doi.org/10.1123/jpah.2016-0389. source
The paper’s Abstract reports that some aerobic exercise interventions reduced the atherogenic index of plasma, a lipid ratio, but also says intervention results were mixed: interval and resistance training showed no significant change. It does not report effects on apolipoproteins, and its own NHANES analysis was observational rather than a trial. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [25] Jeon YK, Kim SS, Kim JH, Kim HJ, Kim HJ, Park JJ, et al. Combined aerobic and resistance exercise training reduces circulating apolipoprotein J levels and improves insulin resistance in postmenopausal diabetic women. Diabetes Metab. 2020;44(1):103–12. https://doi.org/10.4093/dmj.2018.0160. source
The Results report that exercise significantly reduced circulating ApoJ, supporting a positive effect on an apolipoprotein biomarker in the postmenopausal women with type 2 diabetes studied. The paper does not report an exercise-related improvement in lipid ratios; its Discussion instead says there was no discernible close relationship between changes in ApoJ and lipid profiles. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
A recent comparison of high-intensity versus moderate-intensity aerobic exercise on lipids suggested that antiatherogenic HDL-C is positively affected by high intensity more than moderate intensity exercise.
“Our recent comparison of the effects of high-intensity versus moderate-intensity aerobic exercise on lipids suggested that antiatherogenic HDL-C is positively affected by high intensity more than moderate intensity exercise [101].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [101] Wood G, Murrell A, van der Touw T, Smart N. HIIT is not superior to MICT in altering blood lipids: a systematic review and meta-analysis. BMJ Open Sport Exerc Med. 2019;5:e000647. https://doi.org/10.1136/bmjsem-2019-000647. source
- Study design and conductcitation
A potential limitation of the study is the use of aggregated randomized controlled trial data and not individual subject data, with the exception of one study.
“A potential limitation of our work is the use of aggregated RCT data and not individual subject data [113, 114], with the exception of one study [86].”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [113] Greenland S, Morgenstern H. Ecological bias, confounding, and effect modification. Int J Epidemiol. 1989;18(1):269–74. https://doi.org/10.1093/ije/18.1.269. source
- cites [114] Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol. 2005;5:14. https://doi.org/10.1186/1471-2288-5-14. source
- cites [86] Sigal RJ, Kenny GP, Boulé NG, Wells GA, Prud’homme D, Fortier M, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes. Ann Intern Med. 2007;147(6):357-W71. https://doi.org/10.7326/0003-4819-147-6-200709180-00005. source
- Premisecitation
A decrease in atherogenic lipoproteins and sub-fractions is associated with a similar reduction in coronary heart disease.
“Such a decrease in atherogenic lipoproteins and sub-fractions is also associated with a similar reduction in coronary heart disease [105–107].”
- Also stated in: § Conclusion · plain
“positive changes in these biomarkers are associated with reduction in CVD risk.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [105] Robinson JG, Wang S, Jacobson TA. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Am J Cardiol. 2012;110(10):1468–76. https://doi.org/10.1016/j.amjcard.2012.07.007. source
- cites [106] Su X, Kong Y, Peng D. Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol. Lipids Health Dis. 2019;18(1):134. https://doi.org/10.1186/s12944-019-1080-x. source
The ‘Non-HDL-C as a better target of lipid-lowering therapy’ section reports an approximately one-to-one relationship between percentage non-HDL-C lowering and CHD reduction for most lipid-modifying drugs used alone. The Introduction says non-HDL-C encompasses multiple atherogenic lipoproteins, but the reported relationship concerns their combined measure, not reductions in each lipoprotein sub-fraction separately. Page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [107] Gentile M, Iannuzzi A, Giallauria F, D’Andrea A, Venturini E, Pacileo M, et al. Association between very low-density lipoprotein cholesterol (VLDL-C) and carotid intima-media thickness in postmenopausal women without overt cardiovascular disease and on LDL-C target levels. J Clin Med. 2020;9(5):1422. https://doi.org/10.3390/jcm9051422. source
The Introduction states that lowering LDL-C is associated with reduced cardiovascular disease, and the Discussion links higher atherogenic remnant levels with cardiovascular events. The paper does not establish that decreases across atherogenic lipoprotein subfractions produce a similar or proportional reduction in coronary heart disease; its own study measured carotid intima-media thickness, not coronary events. No page numbers are available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Also stated in: § Conclusion · plain
- Interpretationreasoning
To obtain larger effects on the lipid cardiovascular disease risk biomarkers measured and their associated reductions in CVD incidence, the volume and intensity of weekly aerobic exercise training may need to be increased above global guidelines of 150 min of moderate intensity or 75 min of vigorous intensity per week to the thresholds described above.
“To obtain larger effects on both the lipid CVD risk biomarkers we measured and their associated reductions in CVD incidence, the volume and intensity of weekly AET may need to be increased above global guidelines of 150 min of moderate intensity AET or 75 min of vigorous intensity AET per week [110] to the thresholds described above.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [110] Guthold R, Stevens G, Riley LM, Bull F. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health. 2018;6(10):e1077–86. https://doi.org/10.1016/S2214-109X(18)30357-7. source
- Premisecitation
These cardiovascular disease risk biomarkers appear to be superior predictors of cardiovascular disease risk compared to the standard lipid profile.
“which appear to be superior predictors of CVD risk compared to the SLP [4, 5, 9–14].”
Quote in the paperSubstantial claim5 of 8 sources checked- cites [4] Calling S, Johansson S-E, Wolff M, Sundquist J, Sundquist K. The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women’s health in the Lund area (WHILA): a 17-year follow-up cohort study. BMC Cardiovasc Disord. 2019;19(1):239. https://doi.org/10.1186/s12872-019-1228-7. source
The Discussion (page unavailable) reports that a higher TC/HDL-C ratio was associated with greater acute myocardial infarction risk in middle-aged women. It does not establish that this ratio—or cardiovascular biomarkers generally—predicts cardiovascular disease better than a standard lipid profile; the Background notes a study finding no advantage over total cholesterol alone. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [5] Millán J, Pintó X, Muñoz A, Zúñiga M, Rubiés-Prat J, Pallardo LF, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–65.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [9] Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein b in the prediction of coronary heart disease in men. Circulation. 2005;112(22):3375–83. https://doi.org/10.1161/CIRCULATIONAHA.104.532499. source
The Discussion reports that non-HDL-C was more strongly associated with coronary heart disease than LDL-C, and that apoB had the strongest association in this male cohort. That supports a comparison with LDL-C, but the paper does not establish that these biomarkers outperform the entire standard lipid profile for cardiovascular disease risk generally. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [10] Chan DC, Watts GF. Apolipoproteins as markers and managers of coronary risk. QJM Int J Med. 2006;99(5):277–87. https://doi.org/10.1093/qjmed/hcl027. source
- cites [11] Wang F, Wang X, Ye P, Cao R, Zhang Y, Qi Y, et al. High-density lipoprotein 3 cholesterol is a predictive factor for arterial stiffness: a community-based 4.8-year prospective study. Lipids Health Dis. 2018;17(1):5. https://doi.org/10.1186/s12944-017-0650-z. source
The Results (Association of baseline HDL subfractions with follow-up arterial stiffness; page unavailable) report that HDL3-C was associated with later arterial stiffness, including after adjustment for standard lipid measures. The paper does not establish that these biomarkers are superior to the standard lipid profile at predicting CVD risk: its measured outcome was arterial stiffness, not CVD events, and it did not report a direct comparison of CVD-risk prediction. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [12] Sandhu PK, Musaad SMA, Remaley AT, Buehler SS, Strider S, Derzon JH, et al. Lipoprotein biomarkers and risk of cardiovascular disease: a laboratory medicine best practices (LMBP) systematic review. J Appl Lab Med. 2016;1(2):214–29. https://doi.org/10.1373/jalm.2016.021006. source
The Results (Apo B and Apo B/apo A-I) conclude that adding those biomarkers to traditional risk factors improves CVD risk prediction. But the Discussion (Best practices recommendations; Future research needs) says the review did not assess whether the biomarkers predict risk better than, or could replace, traditional measures. It also found insufficient evidence to draw that conclusion for apo A-I and non-HDL-C. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [13] Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen M, de Graaf J, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4(3):337–45. https://doi.org/10.1161/CIRCOUTCOMES.110.959247. source
The Discussion reports that apoB predicts cardiovascular risk more accurately than non-HDL-C, which in turn outperforms LDL-C. The paper compares these individual markers, principally against LDL-C; it does not establish that the biomarkers outperform the standard lipid profile as a whole. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [14] Schmidt C, Bergström G. Apolipoprotein B/apolipoprotein A-I ratio and apolipoprotein B: long-term predictors of myocardial infarction in initially healthy middle-aged men—a 13-year follow-up. Angiology. 2013;65(10):901–5. https://doi.org/10.1177/0003319713511849. source
- Premisecitation
An aerobic exercise training protocol of at least 180 min per week at > 40% VO2MAX or > 1200 kcal/week has a beneficial influence on lipids.
“Other studies have found that an AET protocol of at least 180 min per week at > 40% VO2MAX or > 1200 kcal/week has a beneficial influence on lipids [45, 46, 108, 109].”
Quote in the paperSubstantial claim1 of 4 sources checked- cites [45] Hespanhol Junior LC, Pillay JD, van Mechelen W, Verhagen E. Meta-analyses of the effects of habitual running on indices of health in physically inactive adults. Sports Med. 2015;45(10):1455–68. https://doi.org/10.1007/s40279-015-0359-y. source
The Results section (page not available) reports that running reduced triglycerides and increased HDL cholesterol in physically inactive adults, but found no significant LDL-cholesterol effect. The paper does not establish the claimed thresholds of at least 180 minutes per week, >40% VO2max, or >1200 kcal per week for lipid benefits. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [46] Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, et al. Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. JAMA Intern Med. 2007;167(10):999–1008. https://doi.org/10.1001/archinte.167.10.999. source
- cites [108] Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347(19):1483–92. https://doi.org/10.1056/NEJMoa020194. source
- cites [109] Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD. Blood lipid and lipoprotein adaptations to exercise. Sports Med. 2001;31(15):1033–62. https://doi.org/10.2165/00007256-200131150-00002. source
- Study design and conductcitation
The study followed a rigorous inclusion/exclusion protocol to ensure minimisation of confounding factors amongst the randomized controlled trial populations.
“We followed a rigorous inclusion/exclusion protocol to ensure minimisation of confounding factors amongst the RCT populations [112].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [112] Berman NG, Parker RA. Meta-analysis: neither quick nor easy. BMC Med Res Methodol. 2002;2(1):10. https://doi.org/10.1186/1471-2288-2-10. source
The Methods section, “Defining the Population of Studies Included in the Meta-Analysis” (page not specified), recommends protocol-defined inclusion and exclusion criteria to safeguard against selection bias. It does not say that such criteria minimise confounding factors among RCT populations. The citing authors’ statement that they followed a protocol is their own account, not something this source can verify. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Study design and conductcitation
Included studies exceeded the minimum number of effect sizes to be pooled.
“Included studies exceeded the minimum number of effect sizes to be pooled [98].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [98] Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. https://doi.org/10.1136/bmj.d4002 source
Box 2 (page unavailable) recommends a rule-of-thumb minimum of 10 studies for testing funnel plot asymmetry, not a minimum number of effect sizes required for pooling. The source does not report how many studies or effect sizes the citing analysis included, so it cannot establish that they exceeded a minimum. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
A one standard deviation increment of apolipoprotein A1 (Apo A1) is associated with a reduced hazard ratio of major cardiovascular events.
“A one SD increment of Apo A1 is associated with a reduced hazard ratio of major cardiovascular events [103, 104].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [103] Boekholdt SM, Arsenault BJ, Hovingh GK, Mora S, Pedersen TR, Larosa JC, et al. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation. 2013;128(14):1504–12. https://doi.org/10.1161/CIRCULATIONAHA.113.002670. source
- cites [104] Dominiczak MH, Caslake MJ. Apolipoproteins: metabolic role and clinical biochemistry applications. Ann Clin Biochem. 2011;48(6):498–515. https://doi.org/10.1258/acb.2011.011111. source
The Introduction reports a lower relative risk of myocardial infarction for a one-SD change in ApoAI (RR 0.67). It also reports a lower hazard ratio for ApoAI in a mortality study (HR 0.48), but does not specify that this HR is per one-SD increment; after adjustment, ApoAI was not among the significant predictors of coronary heart disease death. The source therefore supports the inverse association, but not the precise claim of a reduced hazard ratio for major cardiovascular events per one-SD increment. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingown data
Aerobic exercise training significantly raised antiatherogenic apolipoproteins and lipoprotein sub-fractions in mmol/L (mean difference 0.047, 95% CI 0.011 to 0.082, P = .01).
“Multivariate meta-analysis showed AET significantly raised antiatherogenic apolipoproteins and lipoprotein sub-fractions (mmol/L mean difference (MD) 0.047 (95% confidence interval (CI) 0.011, 0.082), P = .01)”
- Also stated in: § Comparative Outcomes · plain
“Antiatherogenic Apo A1 and A2, with or without the inclusion of HDL2 and HDL3, and independent of unit of measurement, were statistically significantly raised by AET, as shown in Fig. 2 (mmol/L MD 0.047 (95% CI 0.011, 0.082), P = 0.01)”
Quote in the paperSubstantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Also stated in: § Comparative Outcomes · plain
- Findingown data
Aerobic exercise training significantly raised antiatherogenic apolipoproteins Apo A1 and A2 reported in mg/dL (mean difference 2.297, 95% CI 0.441 to 4.153, P < 0.02).
“Antiatherogenic Apo A1 and A2, with or without the inclusion of HDL2 and HDL3, and independent of unit of measurement, were statistically significantly raised by AET, as shown in Fig. 2 (mmol/L MD 0.047 (95% CI 0.011, 0.082), P = 0.01) and Fig. 3 (mg/dL MD 2.297 (95% CI 0.441, 4.153), P < 0.02) below.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Findingown data
Aerobic exercise training volume (session minutes, sessions per week, aerobic training intensity, and intervention duration) is associated with positive change in atherogenic lipid, sub-fraction and apolipoprotein ratios.
“AET volume (session minutes, sessions per week, aerobic training intensity, and intervention duration) is associated with positive change in atherogenic lipid, sub-fraction and apolipoprotein ratios.”
Quote in the paperSubstantial claim - Findingown data
Aerobic exercise training improved atherogenic lipid ratios (mean difference −0.201, 95% CI −0.291 to −0.111, P < .0001).
“improved atherogenic lipid ratios (MD − 0.201 (95% CI − 0.291, − 0.111), P < .0001)”
- Also stated in: § Comparative Outcomes · plain
“The joined TC/HDL-C + LDL-C/HDL-C + Apo B100/Apo A1 ratio was reduced with AET by a statistically significant amount, as shown in Fig. 4 (MD − 0.201 (95% CI − 0.291, − 0.111), P < 0.001).”
Quote in the paperSubstantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Also stated in: § Comparative Outcomes · plain
- Findingown data
Aerobic exercise training lowered atherogenic apolipoproteins and lipoprotein sub-fractions in mmol/L (mean difference −0.08, 95% CI −0.161 to 0.0003, P = .05).
“lowered atherogenic apoliproteins and lipoprotein sub-fractions (mmol/L MD − 0.08 (95% CI − 0.161, 0.0003), P = .05)”
Quote in the paperSubstantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Findingown data
Multivariate meta-regression showed intervention variables contributed to change in lipid, sub-fraction, and apolipoprotein ratios.
“Multivariate meta-regression showed intervention variables contributed to change in lipid, sub-fraction, and apoliprotein ratios.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Findingown data
Participant data for pre-post body weight, body fat or lean mass, waist circumference or BMI, systolic and diastolic blood pressure, and fasting blood glucose were missing in the included randomized controlled trials.
“Participant data for pre–post body weight, body fat or lean mass, waist circumference or BMI, systolic and diastolic blood pressure, and fasting blood glucose, were also missing.”
Quote in the paperSubstantial claim - Findingown data
For RCTs with a study quality score ≥ 10, aerobic exercise training reduced the combined biomarker Apo B100 + VLDL-C by a statistically significant amount of 0.08 mmol/L.
“For RCTs with a study quality score ≥ 10, AET reduced the combined biomarker Apo B100 + VLDL-C by the statistically significant amount of 0.08 mmol/L.”
Quote in the paperSubstantial claim - Findingown data
Increasing aerobic exercise training volumes (intensity, frequency, duration and chronicity) are associated with a beneficial change in lipid ratios that are considered highly indicative of cardiovascular disease risk.
“We found that increasing AET volumes (intensity, frequency, duration and chronicity) are associated with a beneficial change in lipid ratios that are considered highly indicative of CVD risk.”
Quote in the paperSubstantial claim - Findingown data
In randomized controlled trials with a TESTEX score of at least 10, aerobic exercise training significantly lowered atherogenic Apo B100 combined with VLDL in mmol/L (mean difference −0.08, 95% CI −0.161 to 0.000, P = 0.05).
“Sub-analyses using TESTEX scores ≥ 10 resulted in statistical significance for atherogenic Apo B100 combined with VLDL, as shown in Fig. 5 (mmol/L MD − 0.08 (95% CI − 0.161, 0.000), P = 0.05)”
- Also stated in: § Discussion · plain
“our study quality sensitivity analyses showed that atherogenic Apo B100 + VLDL mmol/L achieved a statistically significant effect size for RCTs with a study quality score ≥ 10.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Also stated in: § Discussion · plain
- Findingown data
Aerobic exercise training intervention volume (intensity, session minutes, sessions per week, and intervention duration) contributes to positive change in cardiovascular disease risk biomarkers, based on exploratory meta-regression.
“Our exploratory meta-regression analysis indicated that AET intervention volume (intensity, session minutes, sessions per week, and intervention duration) contribute to positive change in these CVD risk biomarkers.”
- Also stated in: § Conclusion · hedged
“our exploratory meta-regression suggested AET volume is associated with change in lipid ratios and antiatherogenic apolipoproteins and lipoprotein sub-fractions.”
Quote in the paperSubstantial claim - Also stated in: § Conclusion · hedged
- Findingown data
Maximum likelihood modelling of intervention and study covariates, whether singly or combined, alluded to overfitting of the data for the antiatherogenic outcome Apo A1 + Apo A2 + HDL2 + HDL3 mmol/L.
“Our maximum likehood modelling of intervention and study covariates, whether singly or combined, alluded to overfitting of the data for antiatherogenic outcome Apo A1 + Apo A2 + HDL2 + HDL3 mmol/L; see Tables S14a and b (OSM).”
Quote in the paperNot a substantial claim - Findingown data
Aerobic exercise training volume (intensity, minutes per session, sessions per week, and intervention duration) is associated with improvement in the joined TC/HDL-C + LDL-C/HDL-C + Apo B100/Apo A1 ratio (τ2 = 0.0023, R2 = 0.84).
“Exploratory multivariate meta-regression modelling of significant results suggested an association between AET volume (intervention covariates: intensity, minutes per session, sessions per week, and intervention duration) and improvement in the joined TC/HDL-C + LDL-C/HDL-C + Apo B100/Apo A1 ratio (τ2 = 0.0023, R2 = 0.84)”
Quote in the paperSubstantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Findingown data
Publication year was minimally associated with improvement in the joined TC/HDL-C + LDL-C/HDL-C + Apo B100/Apo A1 ratio (τ2 = 0.0134, R2 = 0.07).
“The study covariate publication year was minimally associated with improvement in the joined TC/HDL-C + LDL-C/HDL-C + Apo B100/Apo A1 ratio (τ2 = 0.0134, R2 = 0.07)”
- Also stated in: § Discussion · hedged
“Our results suggest that the study covariate publication year is only minimally associated with improvement in lipid and apolipoprotein ratios.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Also stated in: § Discussion · hedged
- Findingown data
Study reporting of protocol adherence and intensity varied among the included randomized controlled trials.
“Study reporting of protocol adherence and intensity varied.”
Quote in the paperNot a substantial claim - Findingown data
None of the included randomized controlled trials reported aggregated baseline lipid values suggesting extreme dyslipidaemia.
“None of our included RCTs reported aggregated baseline lipid values suggesting extreme dyslipidaemia”
Quote in the paperNot a substantial claim - Findingown data
Aerobic exercise training programs of moderate intensity with a minimum 12-week duration significantly reduced Apo B100 and VLDL values in sedentary adults free of chronic disease other than possible metabolic syndrome factors.
“This multivariate meta-analysis with meta-regression of pooled data indicated that AET programs of moderate intensity with a minimum 12-week duration significantly reduced the joint TC/HDL-C, LDL-C/HDL-C and Apo B100/Apo A1 ratios, as well as Apo B100 and VLDL values, while significantly raising Apo A1 and A2 and the sub-fractions HDL2 and HDL3, in sedentary adults free of chronic disease other th”
Quote in the paperSubstantial claim - Findingown data
No included randomized controlled trials reported including next-generation DNA-sequencing.
“and no RCTs reported including this technique.”
Quote in the paperNot a substantial claim - Findingown data
Phlebotomy specifics of post-intervention blood extraction methodology and analyses were not always recorded in the included randomized controlled trials.
“Phlebotomy specifics of post-intervention blood extraction methodology and analyses were not always recorded.”
Quote in the paperNot a substantial claim - Findingown data
Antiatherogenic apolipoproteins were statistically significantly increased with aerobic exercise training (AET) by 0.05 mmol/L or 2.30 mg/dL, grouped by unit of measurement.
“Antiatherogenic apolipoproteins were statistically significantly increased with AET by 0.05 mmol/L or 2.30 mg/dL (grouped by unit of measurement).”
Quote in the paperSubstantial claim - Findingown data
In the main multivariate analysis, aerobic exercise training did not significantly lower Apo B100 combined with VLDL in mmol/L (mean difference −0.053, 95% CI −0.114 to 0.008, P = 0.087).
“Apo B100 + VLDL mmol/L | − 0.053 | − 0.114 | 0.008 | 0.087 | 535 | 360 | 895”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The raw data in the multivariate random effects model are normally distributed.
- Findingown data
Aerobic exercise training affects lipoprotein sub-fractions, ratios and apolipoproteins.
“Aerobic exercise training has been shown to affect lipoprotein sub-fractions, ratios and apolipoproteins”
Quote in the paperSubstantial claim - Findingown data
Aerobic exercise training programs of moderate intensity with a minimum 12-week duration significantly raised Apo A1 and A2 in sedentary adults free of chronic disease other than possible metabolic syndrome factors.
“This multivariate meta-analysis with meta-regression of pooled data indicated that AET programs of moderate intensity with a minimum 12-week duration significantly reduced the joint TC/HDL-C, LDL-C/HDL-C and Apo B100/Apo A1 ratios, as well as Apo B100 and VLDL values, while significantly raising Apo A1 and A2 and the sub-fractions HDL2 and HDL3, in sedentary adults free of chronic disease other th”
Quote in the paperSubstantial claim - Findingown data
Aerobic exercise training programs of moderate intensity with a minimum 12-week duration significantly raised the sub-fractions HDL2 and HDL3 in sedentary adults free of chronic disease other than possible metabolic syndrome factors.
“This multivariate meta-analysis with meta-regression of pooled data indicated that AET programs of moderate intensity with a minimum 12-week duration significantly reduced the joint TC/HDL-C, LDL-C/HDL-C and Apo B100/Apo A1 ratios, as well as Apo B100 and VLDL values, while significantly raising Apo A1 and A2 and the sub-fractions HDL2 and HDL3, in sedentary adults free of chronic disease other th”
Quote in the paperSubstantial claim - Interpretationreasoning
Cardiovascular disease risk predicted by these biomarkers may be lowered when aerobic exercise training is prescribed as treatment or prevention.
“Cardiovascular disease risk predicted by these biomarkers may be lowered when AET is prescribed as treatment or prevention.”
Quote in the paperSubstantial claim - Premisecitation
Lack of aerobic physical activity increases cardiovascular disease risk.
“Lack of aerobic physical activity increases CVD risk [16].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Slentz CA, Houmard JA, Johnson JL, Bateman LA, Tanner CJ, McCartney JS, et al. Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol (1985). 2007;103(2):432–42. https://doi.org/10.1152/japplphysiol.01314.2006. source
- Study design and conductown data
No randomized controlled trial attained a TESTEX score of at least 10 with a high within-study risk of bias score.
“No RCT attained a TESTEX score ≥ 10 with a high within-study risk of bias score.”
Quote in the paperNot a substantial claim - Study design and conductown data
There was minimal to no evidence of potential small study effects for each statistically significant outcome after multiple small-study effect analyses and funnel plot inspection.
“There was minimal to no evidence of potential small study effects for each of the statistically significant outcomes after analysis with Classic fail-safe N, Orwin’s fail-safe N, Duval and Tweedie’s trim-and-fill, Egger’s regression test, and Begg and Mazumdar’s rank correlation test, nor following visual inspection of precision and standard error funnel plots.”
Quote in the paperSubstantial claim - Study design and conductown data
The median study quality TESTEX score was 10 (range 6-15).
“The median study quality TESTEX score was 10 (from a maximum score of 15; range 6–15), see Table S5 (OSM).”
Quote in the paperNot a substantial claim - Interpretationreasoning
The estimated 2.073 mg/dL decrease in ApoB100 could anticipate a 4.34% decrease in coronary heart disease.
“we calculate that our estimated 2.073 mg/dL decrease in ApoB100 could anticipate a 4.34% decrease in coronary heart disease.”
Quote in the paperSubstantial claim - Premisecitation
A 9% reduction in coronary heart disease occurs for every 10 mg/dL reduction in apolipoprotein B100 (ApoB100).
“Given that a 9% reduction in coronary heart disease occurs for every 10 mg/dL reduction in ApoB100 [105]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [105] Robinson JG, Wang S, Jacobson TA. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Am J Cardiol. 2012;110(10):1468–76. https://doi.org/10.1016/j.amjcard.2012.07.007. source
- Study design and conductreasoning
Since the meta-regression covariates were not randomised at study level, the meta-regression findings are best viewed as exploratory.
“Since our meta-regression covariates were not randomised at study level, our meta-regression findings are best viewed as exploratory.”
Quote in the paperNot a substantial claim - Study design and conductnone given
Where the standard deviation of the mean difference, exact P values within groups, or 95% confidence intervals were not available, statistical analyses depended on extrapolated data.
“With respect to data pooling, where the standard deviation of the mean difference, or exact P values within groups, or 95% CIs were not available, statistical analyses depended on extrapolated data.”
Quote in the paperSubstantial claim - Interpretationreasoning
Extraction techniques and measurement are unlikely to explain variation in results of individual randomized controlled trials investigating the effects of aerobic exercise training.
“Extraction techniques and measurement would thus be unlikely to explain variation in results of individual RCTs investigating the effects of AET.”
Quote in the paperSubstantial claim - Study design and conductown data
Sub-analyses using K − 1 sensitivity analysis for statistically significant outcomes did not change the results.
“Sub-analyses using K − 1 sensitivity analysis for statistically significant outcomes did not change the results; see Figs. S1–S3 (OSM).”
Quote in the paperNot a substantial claim - Interpretationreasoning
Bias in the measurement of data reported in the included randomized controlled trials may have occurred.
“Bias in the measurement of data reported in the included RCTs may have thus occurred.”
Quote in the paperNot a substantial claim - Study design and conductown data
Within-study risk of bias was mainly low or medium.
“Within-study risk of bias was mainly low or medium, see Table S6 (OSM).”
Quote in the paperNot a substantial claim - Interpretationown data
Advances in lipid and apolipoprotein extraction techniques and measurement, if represented by publication year, may have a limited influence on the changes observed in these biomarkers as a result of aerobic exercise training.
“Advances in lipid and apolipoprotein extraction techniques and measurement, if represented by the study covariate publication year, may have a limited influence on the changes observed in these biomarkers as a result of AET.”
Quote in the paperSubstantial claim - Study design and conductown data
Sensitivity analysis according to analytical method, when possible to perform, did not change the results.
“however, sensitivity analysis according to analytical method, when possible to perform, did not change the results (data not shown).”
Quote in the paperNot a substantial claim - Interpretationown data
The study's results mimic the results of previous reviews examining standard lipid cardiovascular disease risk biomarkers.
“Our results mimic the results of previous reviews examining standard lipid CVD risk biomarkers”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 23
- May combine two claims. 24
Classified as probably not a substantial claim.
Study design and conductcitationStudies with intervention and control group sample sizes less than 10 were excluded to reduce the likelihood of small study effects, such as over-estimation of effect size.
“Studies of intervention and control group population sample sizes (N) < 10 were excluded to reduce the likelihood of small study effects, for example over-estimation of effect size [33].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [33] Hackshaw A. Small studies: strengths and limitations. Eur Respir J. 2008;32:1141–3. https://doi.org/10.1183/09031936.00136408. source
The LIMITATIONS section says small studies can overestimate the magnitude of an association, supporting the stated reason for exclusion. The HOW SMALL IS 'SMALL'? section says appropriate sample size depends on the expected effect; it does not establish fewer than 10 participants per group as a cutoff. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationSub-fractions of HDL-C may be more relevant in identifying cardiovascular disease risk than HDL-C.
“Sub-fractions of HDL-C may be more relevant in identifying CVD risk than HDL-C [11].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [11] Wang F, Wang X, Ye P, Cao R, Zhang Y, Qi Y, et al. High-density lipoprotein 3 cholesterol is a predictive factor for arterial stiffness: a community-based 4.8-year prospective study. Lipids Health Dis. 2018;17(1):5. https://doi.org/10.1186/s12944-017-0650-z. source
May combine two claims.
PremisecitationSystematic reviews found that Apo B100 and the Apo B100/Apo A1 ratio improved prediction of cardiovascular risk.
“Systematic reviews have examined the risk prediction power of Apo A1, A2 and B100 for cardiovascular risk and found Apo B100 and the Apo B100/Apo A1 ratio improved prediction [12–14].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [12] Sandhu PK, Musaad SMA, Remaley AT, Buehler SS, Strider S, Derzon JH, et al. Lipoprotein biomarkers and risk of cardiovascular disease: a laboratory medicine best practices (LMBP) systematic review. J Appl Lab Med. 2016;1(2):214–29. https://doi.org/10.1373/jalm.2016.021006. source
- cites [13] Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen M, de Graaf J, et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4(3):337–45. https://doi.org/10.1161/CIRCOUTCOMES.110.959247. source
The Summary (page not provided) concludes that apoB is a better predictor of cardiovascular risk than non-HDL-C or LDL-C. The paper does not report a finding that the apoB/apoA-I ratio improves prediction, and its analysis does not examine apoA-I or apoA-II as predictors. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [14] Schmidt C, Bergström G. Apolipoprotein B/apolipoprotein A-I ratio and apolipoprotein B: long-term predictors of myocardial infarction in initially healthy middle-aged men—a 13-year follow-up. Angiology. 2013;65(10):901–5. https://doi.org/10.1177/0003319713511849. source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent 17-year follow-up study of females concluded that the TC/HDL-C ratio was a potent predictor of cardiovascular disease events.
“A recent 17-year follow-up study of females concluded the TC/HDL-C ratio was a potent predictor of CVD events [4].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [4] Calling S, Johansson S-E, Wolff M, Sundquist J, Sundquist K. The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women’s health in the Lund area (WHILA): a 17-year follow-up cohort study. BMC Cardiovasc Disord. 2019;19(1):239. https://doi.org/10.1186/s12872-019-1228-7. source
The Abstract Conclusions call TC/HDL-C a powerful predictor of acute myocardial infarction (AMI) in middle-aged women, and the Discussion reports a strong association over a mean 17-year follow-up. The cited study examined AMI, not cardiovascular disease events broadly, so the claim extends its conclusion beyond the studied outcome. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationAt least moderate intensity effort (>40% VO2MAX) is the minimum recommended for sedentary individuals.
“Studies of either prescribed steady-state or interval AET that employed at least a moderate intensity effort (> 40% VO2MAX) were included, since this intensity is the minimum recommended for sedentary individuals [36, 37].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [36] Pollock ML, Gaesser GA, Butcher JD, Després J-P, Dishman RK, Franklin BA, et al. ACSM position stand: the recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc. 1998;30(6):975–91. https://doi.org/10.1097/00005768-199806000-00032. source
- cites [37] Swain DP. Moderate or vigorous intensity exercise: which is better for improving aerobic fitness? Prev Cardiol. 2005;8(1):55–8. https://doi.org/10.1111/j.1520-037X.2005.02791.x. source
In “Increasing Aerobic Fitness” (p. 55), the paper identifies 40% VO₂ reserve as the lower recommended threshold for very-low-fit clients, versus 50% for most clients. This supports a lower threshold for some low-fitness individuals, but it does not state that >40% VO₂max is the minimum recommended for sedentary individuals generally; VO₂ reserve and VO₂max are different measures. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAerobic exercise training positively affects dyslipidaemia and Metabolic Syndrome and lowers cardiovascular disease risk.
“Aerobic exercise training (AET) positively affects dyslipidaemia and MetS [17–20] and lowers CVD risk [21, 22].”
Quote in the paperSubstantial claim2 of 6 sources checked- cites [17] Greene NP, Martin SE, Crouse SF. Acute exercise and training alter blood lipid and lipoprotein profiles differently in overweight and obese men and women. Obesity. 2012;20(8):1618–27. https://doi.org/10.1038/oby.2012.65. source
- cites [18] O’Donovan G, Owen A, Bird SR, Kearney EM, Nevill AM, Jones DW, et al. Changes in cardiorespiratory fitness and coronary heart disease risk factors following 24 wk of moderate- or high-intensity exercise of equal energy cost. J Appl Physiol (1985). 2005;98(5):1619–25. https://doi.org/10.1152/japplphysiol.01310.2004. source
- cites [19] Fikenzer K, Fikenzer S, Laufs U, Werner C. Effects of endurance training on serum lipids. Vasc Pharmacol. 2018;101:9–20. https://doi.org/10.1016/j.vph.2017.11.005. source
- cites [20] Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med. 2014;44(2):211–21. https://doi.org/10.1007/s40279-013-0110-5. source
The Findings > Aerobic Exercise section reports improved lipid profiles with aerobic training, supporting the dyslipidaemia part. The Conclusion links physical activity and improved cholesterol to reduced risks of heart attacks, strokes and coronary artery disease, but the copy does not address Metabolic Syndrome or establish a direct reduction in CVD events from aerobic training. Page numbers were not available in the supplied copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [21] Wood G, Taylor E, Ng V, Murrell A, Patil A, van der Touw T, et al. Determining the effect size of aerobic exercise training on the standard lipid profile in sedentary adults with three or more metabolic syndrome factors: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med. 2022;56(18):1032–41. https://doi.org/10.1136/bjsports-2021-103999. source
- cites [22] Pattyn N, Cornelissen VA, Eshghi SRT, Vanhees L. The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med. 2013;43(2):121–33. https://doi.org/10.1007/s40279-012-0003-z. source
The Results report improvements in HDL-C, blood pressure and waist circumference after dynamic endurance training in patients with metabolic syndrome; triglycerides were statistically unaltered. The Discussion reports improvements in other lipid measures and says the changes are compatible with lower cardiovascular risk, but it estimates that risk reduction rather than demonstrating it directly. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S4 (based).
Findingnone givenReporting of apolipoprotein, lipid and sub-fraction ratios is less common than standard lipid outcomes.
“Reporting of apolipoprotein, lipid and sub-fraction ratios is less common than standard lipid outcomes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFifty-seven randomized controlled trials totalling 3194 participants were analysed.
“Fifty-seven RCTs totalling 3194 participants were analysed.”
- Also stated in: § Results · plain
“Screening resulted in the inclusion of 57 RCTs for data extraction, pooling and analysis, published between 1979 and 2020.”
Quote in the paperSubstantial claim- Also stated in: § Results · plain
May combine two claims.
Findingown dataAerobic exercise training programs of moderate intensity with a minimum 12-week duration significantly reduced the joint TC/HDL-C, LDL-C/HDL-C and Apo B100/Apo A1 ratios in sedentary adults free of chronic disease other than possible metabolic syndrome factors.
“This multivariate meta-analysis with meta-regression of pooled data indicated that AET programs of moderate intensity with a minimum 12-week duration significantly reduced the joint TC/HDL-C, LDL-C/HDL-C and Apo B100/Apo A1 ratios, as well as Apo B100 and VLDL values, while significantly raising Apo A1 and A2 and the sub-fractions HDL2 and HDL3, in sedentary adults free of chronic disease other th”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataVariations of the model (restricted maximum likelihood, method of moments) suggested no fit or overfitting, respectively.
“Variations of the model (restricted maximum likelihood, method of moments) suggested no fit or overfitting, respectively (data not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBetter quality studies increased the effect size for Apo B100 reported in mg/dL but did not attain statistical significance.
“Better quality studies increased the effect size for Apo B100 reported in mg/dL but did not attain statistical significance (Table S7, OSM).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone givenSome included randomized controlled trials used objective measures such as electronic devices, while other studies used subjective measures, for example, the Borg scale, self-reported heart rate, and log books, denoted by different indices of intensity.
“Some RCTs used objective measures such as electronic devices. Other studies used subjective measures, for example, the Borg scale, self-reported heart rate, log books, denoted by different indices of intensity (energy expenditure, VO2MAX, maximum heart rate, METs, Borg scale).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor randomized controlled trials (RCTs) reporting apolipoprotein B100 (Apo B100) with a study quality score ≥ 10, aerobic exercise training beneficially decreased Apo B100 by 2.073 mg/dL, although this was not statistically significant.
“While not statistically significant, for RCTs reporting Apo B100 with a study quality score ≥ 10, we showed that AET beneficially decreased Apo B100 by 2.073 mg/dL.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenFew studies reported the Apo B100/Apo A1 ratio.
“Few studies reported the Apo B100/Apo A1 ratio, considered an equivalent if not more accurate lipid CVD risk biomarker in comparison to standard lipid CVD risk biomarkers.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationA TESTEX score of at least 10 is considered good study quality and reporting.
“A score ≥ 10 is considered good study quality and reporting [40].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] Gilson N, Papinczak Z, Mielke G, Haslam C, McKenna J, Brown W. Intervention strategies to promote self-managed physical activity in service veterans and their dependants—a rapid evidence assessment. Brisbane: Centre for Research on Exercise, Physical Activity and Health, The University of Queensland, Australia, Department of Veterans Affairs AG;2019.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationLowered levels of lipoprotein sub-fractions HDL2 and HDL3 are considered to increase cardiovascular disease risk, although HDL3 may be less protective in the presence of Metabolic Syndrome.
“Lowered levels of lipoprotein sub-fractions HDL2 and HDL3 are considered to increase CVD risk, although HDL3 may be less protective in the presence of MetS [15].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] Rye K-A, Bursill CA, Lambert G, Tabet F, Barter PJ. The metabolism and anti-atherogenic properties of HDL. J Lipid Res. 2009;50(Suppl):S195–200. https://doi.org/10.1194/jlr.R800034-JLR200. source
Classified as probably not a substantial claim.
PremisecitationAn aerobic exercise training intervention of at least 12 weeks was considered the minimum time to affect lipid profiles.
“An AET intervention ≥ 12 weeks was considered the minimum time to affect lipid profiles [34, 35].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34] Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc. 2001;33(6):S502–15. https://doi.org/10.1097/00005768-200106001-00021. source
- cites [35] Tambalis K, Panagiotakos DB, Kavouras SA, Sidossis LS. Responses of blood lipids to aerobic, resistance, and combined aerobic with resistance exercise training: a systematic review of current evidence. Angiology. 2008;60(5):614–32. https://doi.org/10.1177/0003319708324927. source
May combine two claims.
Interpretationown dataIn sedentary adults, aerobic exercise training lowers atherogenic apolipoprotein and lipoprotein sub-fractions and lipid ratios, and raises antiatherogenic apolipoproteins and lipoprotein sub-fractions.
“Aerobic exercise training (AET) lowers atherogenic apolipoprotein and lipoprotein sub-fractions and lipid ratios, and raises antiatherogenic apolipoproteins and lipoprotein sub-fractions, in sedentary adults.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataA study quality sub-analysis of randomized controlled trials grouped according to a TESTEX score of at least 10 and a within-study risk evaluation of low-to-medium was conducted.
“A study quality sub-analysis of RCTs grouped according to a TESTEX score ≥ 10 and a within-study risk evaluation of low-to-medium was conducted.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenGW and NS independently entered data in Comprehensive Meta-Analysis and reviewed each other's files for accuracy.
“GW and NS independently entered data in CMA, and reviewed each other’s files for accuracy.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationA leave-one-out sensitivity analysis was performed to evaluate the influence of each randomized controlled trial on the effect size of pooled data.
“A leave-one-out (K − 1, where K = total number of pooled RCTs, and each RCT is excluded once) sensitivity analysis was also performed to evaluate the influence of each RCT on the effect size of pooled data [43].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley; 2008. source
Classified as probably not a substantial claim.
Study design and conductcitationStudy quality was determined using the validated Tool for the Assessment of Study Quality and Reporting in Exercise (TESTEX), a 15-point scale specific to exercise training studies.
“Study quality was determined using the validated Tool for the Assessment of Study Quality and Reporting in Exercise (TESTEX) [39], a 15-point scale specific to exercise training studies”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] Smart NA, Waldron M, Ismail H, Giallauria F, Vigorito C, Cornelissen V, et al. Validation of a new tool for the assessment of study quality and reporting in exercise training studies: TESTEX. Int J Evid Based Healthc. 2015;13(1):9–18. source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationTC/HDL-C and LDL-C/HDL-C ratios better predicted cardiovascular disease risk than the standard lipid profile biomarkers.
“A systematic review collating data from several large observational studies found TC/HDL-C and LDL-C/HDL-C ratios better predicted CVD risk than the SLP biomarkers [5].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] Millán J, Pintó X, Muñoz A, Zúñiga M, Rubiés-Prat J, Pallardo LF, et al. Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–65.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
Study design and conductown dataWithin-study risk of bias was evaluated against seven criteria and scored as low, medium or high.
“Within-study risk-of-bias was evaluated against seven criteria (see Table S4 (OSM)) and a score of low, medium or high was awarded.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAerobic exercise training positively impacts atherogenic lipid and apolipoprotein ratios, apolipoproteins, and lipoprotein sub-fractions, and antiatherogenic apolipoproteins and lipoprotein sub-fractions.
“Aerobic exercise training positively impacts atherogenic lipid and apolipoprotein ratios, alipoproteins, and lipoprotein sub-fractions; and antiatherogenic apolipoproteins and lipoprotein sub-fractions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationHeterogeneity was quantified using the Q statistic, its corresponding P value, τ2, τ, and I2.
“Heterogeneity was quantified using the Q statistic, and the corresponding P value, τ2, τ, and I2 [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111. https://doi.org/10.1002/jrsm.12. source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationRaised levels of Apo A1 and A2 are considered antiatherogenic, while increased levels of Apo B100 and VLDL are atherogenic.
“Raised levels of Apo A1 and A2 are considered to be antiatherogenic, while increased levels of Apo B100 and VLDL are atherogenic [8].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [8] Brewer HB. High-density lipoprotein metabolism. In: Ballantyne CM, editor. Clinical lipidology. Philadelphia: W.B. Saunders; 2009. p. 45–55. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenSmall-study effects were examined using Rosenthal's failsafe N, Orwin's failsafe N, Duval and Tweedie's trim-and-fill, Egger's regression test, Begg and Mazumdar's rank correlation test, and precision and standard error funnel plots.
“Each of Rosenthal’s failsafe N, Orwin’s failsafe N, Duval and Tweedie’s trim-and-fill, Egger’s regression test, Begg and Mazumdar’s rank correlation test, and precision and standard error funnel plots, were used to test for possible small-study effects.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningSome randomized controlled trials reported scant data on aerobic exercise training protocol or energy expenditure, and the study therefore estimated intensity as a percent of VO2MAX.
“Some RCTs reported scant data on AET protocol or energy expenditure, and we therefore estimated intensity as a percent of VO2MAX.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductcitationThe study included aerobic exercise training protocols with an intensity (> 40% VO2MAX) at the lower end of the moderate-intensity range; this low-intensity may elicit very small changes in lipids, and the inclusion of these protocols may have resulted in understated effect sizes.
“We included AET protocols with an intensity (> 40% VO2MAX) at the lower end of the moderate-intensity range; this low-intensity may elicit very small changes in lipids [19], and the inclusion of these protocols may have resulted in understated effect sizes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Fikenzer K, Fikenzer S, Laufs U, Werner C. Effects of endurance training on serum lipids. Vasc Pharmacol. 2018;101:9–20. https://doi.org/10.1016/j.vph.2017.11.005. source
May combine two claims.
Study design and conductreasoningThe imputation of these statistics was conservative and this approach may have weakened results.
“Our imputation of these statistics was conservative and this approach may have weakened results.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataNeither absolute between-study heterogeneity (τ2) nor relative heterogeneity (I2) for each analysed outcome indicated that trials should not be pooled or that significance testing should not be undertaken.
“Neither the degree of absolute between-study heterogeneity (τ2) nor the relative heterogeneity (I2) for each analysed outcome indicated that trials should not be pooled, or that significance testing should not be undertaken; see Table S12 (OSM).”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenThe study searched using English language terms, potentially reducing the pool of available studies for selection and possibly introducing bias.
“We searched using English language terms, potentially reducing the pool of available studies for selection and possibly introducing bias.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenA very small number of randomized controlled trials noted that control groups increased physical activity levels during the duration of the study; this may have reduced the study's estimated effect size.
“A very small number of RCTs noted that control groups increased physical activity levels during the duration of the study; this may have reduced our estimated effect size.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationA minimum effective aerobic exercise training protocol requires an AET volume of > 45 min per session for 3-4 sessions per week for a duration of > 26 weeks at > 65% VO2MAX to positively affect lipids.
“A previous systematic review pooling data from AET interventions compared thresholds of intensity and volume, and determined that a minimum effective AET protocol required an AET volume of > 45 min per session for 3–4 sessions per week for a duration of > 26 weeks at > 65% VO2MAX [19] to positively affect lipids.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Fikenzer K, Fikenzer S, Laufs U, Werner C. Effects of endurance training on serum lipids. Vasc Pharmacol. 2018;101:9–20. https://doi.org/10.1016/j.vph.2017.11.005. source
May combine two claims.
Study design and conductnone givenThe study excluded studies with intervention and comparison group N < 10, and the number of randomized controlled trials included with longer durations were few, which may have reduced estimated effect sizes.
“We excluded studies with intervention and comparison group N < 10, and the number of RCTs included with longer durations were few, which may have reduced estimated effect sizes.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataAerobic exercise training at >40% VO2MAX for at least 12 weeks achieved better outcomes than no exercise for lipoprotein sub-fractions, lipid and apolipoprotein ratios, as well as Apo A1, A2 and B100.
“we have shown that AET at > 40% VO2MAX for ≥ 12 weeks achieved better outcomes than no exercise for lipoprotein sub-fractions, lipid and Apo ratios, as well as Apo A1, A2 and B100”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningIncluded randomized controlled trials extracted blood from individuals in fasted states and in seated or supine positions, and no trial was excluded for phlebotomy reasons.
“The included RCTs extracted blood from individuals in fasted states and in seated or supine positions and thus no RCT was excluded for phlebotomy reasons (data not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe study quality sensitivity results allude to improvements in study design over time and/or the employment of more sensitive lipid assays, irrespective of study publication year.
“These results allude to improvements in study design over time, and/or the employment of more sensitive lipid assays, irrespective of study publication year.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
A comprehensive quantitative review investigating the effects of aerobic exercise training on apolipoproteins, lipoprotein sub-fractions, associated ratios and lipid ratios in adults free of chronic disease other than Metabolic Syndrome factors had not been conducted before this study.
“however, to the best of our knowledge, a comprehensive quantitative review investigating the effects of AET on apolipoproteins, lipoprotein sub-fractions, associated ratios and lipid ratios in adults free of chronic disease other than MetS factors has yet to be conducted.”
The authors state this as an assumption.
The raw data in the multivariate random effects model are normally distributed.
“This model assumes normal distribution of raw data.”
The paper relies on this without support.
This quantitative review is the first to compare the effects of a minimum prescribed aerobic exercise training dose against no exercise on lipid sub-fractions, ratios and apolipoproteins in a cohort free of chronic disease except possible metabolic syndrome factors, using a multivariate meta-analytic approach.
“To the best of our knowledge, this quantitative review is the first to have compared the effects of a minimum prescribed AET dose against no exercise on lipid sub-fractions, ratios and apolipoproteins in a cohort characterised as free of chronic disease except for the possible presence of the CVD risk factors comprising MetS, using a multivariate meta-analytic approach.”
The paper relies on this without support.
Previous systematic reviews did not use TESTEX to measure the quality of included studies.
“Previous systematic reviews did not use TESTEX [39] to measure the quality of included studies.”
The paper relies on this without support.
The Apo B100/Apo A1 ratio is considered an equivalent if not more accurate lipid cardiovascular disease risk biomarker in comparison to standard lipid cardiovascular disease risk biomarkers.
“Few studies reported the Apo B100/Apo A1 ratio, considered an equivalent if not more accurate lipid CVD risk biomarker in comparison to standard lipid CVD risk biomarkers.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previous works were not systematic or included non-randomized trials, and limited pooled data analyses have been previously published.
“Previous works were not systematic [14] or included non-randomized trials [13, 15]; limited pooled data analyses have been previously published [16, 17].”
From The Effect of Exercise Training on Blood Lipids: A Systematic Review and Meta-analysis (2025) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Abstract presents a subgroup result as the overall result
MajorThe abstract reports a significant −0.08 mmol/L result for atherogenic apolipoproteins and sub-fractions. The overall Apo B100 + VLDL analysis in Table 2 instead reports −0.053 mmol/L with P = 0.087; the −0.08 result is identified later as a study-quality sub-analysis.
“lowered atherogenic apoliproteins and lipoprotein sub-fractions (mmol/L MD − 0.08 (95% CI − 0.161, 0.0003), P = .05)”
“| Apo B100 + VLDL mmol/L | − 0.053 | − 0.114 | 0.008 | 0.087 | 535 | 360 | 895 |”
Included trial is listed at the excluded intensity threshold
MinorThe eligibility rule requires intensity above 40% VO2MAX, but Table 1 lists the included Gordon et al. trial at exactly 40%.
“| Gordon et al. [57] | 154 | > 55 | Mx | 1 | 10 | 40 | 24 | 5 | 60 |”
“Studies of either prescribed steady-state or interval AET that employed at least a moderate intensity effort (> 40% VO2MAX) were included”
Reported session-frequency range excludes listed trials
MinorThe stated range of 1.8 to 5.2 sessions per week excludes the listed Ring-Dimitriou trial at 1 session per week. Table 1 also lists Stensel et al. at 7 sessions per week, above the stated maximum.
“Sessions per week ranged from 1.8 to 5.2”
“| Ring-Dimitriou et al. [81] | 30 | 35–55 | Mx | 2 | 9 | 75 | 39 | 1 | 80 |”
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823 · cited 1× · see citing works
“The results are presented according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [29].”
MethodMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1× · see citing works
“The relative measure of heterogeneity I2 ranges from 0% (complete homogeneity) to 100% (complete heterogeneity) [44].”
BackgroundCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · see citing works
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026 · see citing works
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 1× · see citing works
“Included studies exceeded the minimum number of effect sizes to be pooled [98].”
BackgroundA basic introduction to fixed-effect and random-effects models for meta-analysis
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.12 · Cited by 6,793 · see citing works
Guthold, R., Stevens, G. A., Riley, L. M., & Bull, F. C. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30357-7 · Cited by 4,819 · cited 1× · see citing works
“To obtain larger effects on both the lipid CVD risk biomarkers we measured and their associated reductions in CVD incidence, the volume and intensity of weekly AET may need to be increased above global guidelines of 150 min of moderate intensity AET or 75 min of vigorous intensity AET per week [110] to the thresholds…”
BackgroundPollock, M. L., Gaesser, G. A., Butcher, J. D., Despr??s, J.-P., Dishman, R. K., Franklin, B. A., & Garber, C. E. (1998) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199806000-00032 · Cited by 3,051 · cited 1× · see citing works
“Studies of either prescribed steady-state or interval AET that employed at least a moderate intensity effort (> 40% VO2MAX) were included, since this intensity is the minimum recommended for sedentary individuals [36, 37].”
A comprehensive definition for metabolic syndrome
Huang, P. L. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001180 · Cited by 2,223 · see citing works
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706 · cited 1× · see citing works
“Since TRG better predicts CVD risk in women [111], we recommend trials also record, and by sex, non-HDL-C, non-HDL-C/HDL-C and the log ratio of TRG/HDL-C, as these ratios were under-reported in our included RCTs.”
ResultEffects of the amount and intensity of exercise on plasma lipoproteins
Kraus, W. E., Houmard, J. A., Duscha, B. D., Knetzger, K. J., Wharton, M. B., McCartney, J. S., Bales, C. W., Henes, S., Samsa, G. P., Otvos, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020194 · Cited by 1,554 · cited 1× · see citing works
“Other studies have found that an AET protocol of at least 180 min per week at > 40% VO2MAX or > 1200 kcal/ week has a beneficial influence on lipids [45, 46, 108, 109].”
BackgroundThe nuts and bolts of PROSPERO: an international prospective register of systematic reviews
Booth, A., Clarke, M., Dooley, G., Ghersi, D., Moher, D., Petticrew, M., & Stewart, L. (2012) · Systematic Reviews · doi:10.1186/2046-4053-1-2 · Cited by 1,433 · cited 1× · see citing works
“This systematic review with multivariate meta-analysis and meta-regression was designed by GW and NS and registered in the International Prospective Register of Systematic Reviews (PROSPERO) [28], CRD42020151925.”
MethodPrimary Prevention of Ischemic Stroke
Goldstein, L. B., Adams, R. J., Becker, K. J., Furberg, C. D., Gorelick, P. B., Hádemenos, G. J., Hill, M., Howard, G., Howard, V. J., Jacobs, B. S., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 897 · cited 1× · see citing works
“Dyslipidaemia, a lipid profile characterised by abnormally elevated or lowered lipids, is an important Metabolic Syndrome (MetS) risk factor of CVD [2, 3].”
BackgroundMann, S., Beedie, C., & Jimenez, A. (2014) · Sports Medicine · doi:10.1007/s40279-013-0110-5 · Cited by 801 · see citing works
Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention
Muñóz (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6269 · Cited by 756 · see citing works
Wood, P. D., Stefanick, M. L., Dreon, D. M., Frey-Hewitt, B., Garay, S. C., Williams, P. T., Superko, H. R., Fortmann, S. P., Albers, J. J., Vranizan, K. M., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191801 · Cited by 675 · see citing works
Response of blood lipids to exercise training alone or combined with dietary intervention
LEON, A. S., & SANCHEZ, O. A. (2001) · Medicine and Science in Sports and Exercise · doi:10.1097/00005768-200106001-00021 · Cited by 662 · cited 1× · see citing works
“An AET intervention ≥ 12 weeks was considered the minimum time to affect lipid profiles [34, 35].”
BackgroundSniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659 · see citing works
Stefanick, M. L., Mackey, S., Sheehan, M., Ellsworth, N., Haskell, W. L., & Wood, P. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390103 · Cited by 629 · see citing works
A Guide to Conducting a Meta-Analysis with Non-Independent Effect Sizes
Cheung, M. W.-L. (2019) · Neuropsychology Review · doi:10.1007/s11065-019-09415-6 · Cited by 610 · see citing works
Blood Lipid and Lipoprotein Adaptations to Exercise: A Quantitative Analysis
Durstine, J. L., Grandjean, P. W., Davis, P. G., Ferguson, M. A., Alderson, N. L., & DuBose, K. D. (2001) · Sports Medicine · doi:10.2165/00007256-200131150-00002 · Cited by 588 · cited 1× · see citing works
“Other studies have found that an AET protocol of at least 180 min per week at > 40% VO2MAX or > 1200 kcal/ week has a beneficial influence on lipids [45, 46, 108, 109].”
BackgroundEcological Bias, Confounding, and Effect Modification
GREENLAND, S., & MORGENSTERN, H. (1989) · International Journal of Epidemiology · doi:10.1093/ije/18.1.269 · Cited by 540 · cited 1× · see citing works
“A potential limitation of our work is the use of aggregated RCT data and not individual subject data [113, 114], with the exception of one study [86].”
BackgroundPischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514 · see citing works
Smart, N. A., Waldron, M., Ismail, H., Giallauria, F., Vigorito, C., Cornelissen, V., & Dieberg, G. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000020 · Cited by 499 · cited 12× · see citing works
“No RCT attained a TESTEX score ≥ 10 with a high within-study risk of bias score.”
MethodInfluentialSelf-citationSmall studies: strengths and limitations
Hackshaw, A. (2008) · European Respiratory Journal · doi:10.1183/09031936.00136408 · Cited by 496 · cited 1× · see citing works
“Studies of intervention and control group population sample sizes (N) < 10 were excluded to reduce the likelihood of small study effects, for example over-estimation of effect size [33].”
BackgroundWood, P. D., Haskell, W. L., Blair, S. N., Williams, P. T., Krauss, R. M., Lindgren, F. T., Albers, J. J., Ho, P., & Farquhar, J. W. (1983) · Metabolism · doi:10.1016/0026-0495(83)90152-x · Cited by 354 · see citing works
The metabolism and anti-atherogenic properties of HDL
Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800034-jlr200 · Cited by 331 · see citing works
Huttunen, J. K., Länsimies, E., Voutilainen, E., Ehnholm, C., Hietanen, E. K., Penttilä, I., Siitonen, O., & Rauramaa, R. (1979) · Circulation · doi:10.1161/01.cir.60.6.1220 · Cited by 300 · see citing works
O'Donovan, G., Owen, A., Bird, S. R., Kearney, E. M., Nevill, A. M., Jones, D. W., & Woolf-May, K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01310.2004 · Cited by 276 · see citing works
Gordon, L. A., Morrison, E. Y., McGrowder, D. A., Young, R., Fraser, Y. T. P., Zamora, E. M., Alexander-Lindo, R. L., & Irving, R. R. (2008) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-8-21 · Cited by 275 · see citing works
The metabolic syndrome – What is it and how should it be managed?
Nilsson, P. M., Tuomilehto, J. O., & Rydén, L. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319886404 · Cited by 272 · see citing works
Meta-analysis: Neither quick nor easy
Berman, N. G., & Parker, R. A. (2002) · BMC Medical Research Methodology · doi:10.1186/1471-2288-2-10 · Cited by 270 · see citing works
Pattyn, N., Cornelissen, V. A., Eshghi, S. R. T., & Vanhees, L. (2013) · Sports Medicine · doi:10.1007/s40279-012-0003-z · Cited by 266 · see citing works
Meta-Analyses of the Effects of Habitual Running on Indices of Health in Physically Inactive Adults
Hespanhol Junior, L. C., Pillay, J. D., van Mechelen, W., & Verhagen, E. (2015) · Sports Medicine · doi:10.1007/s40279-015-0359-y · Cited by 265 · see citing works
The strengths and limitations of meta-analyses based on aggregate data
Lyman, G. H., & Kuderer, N. M. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-14 · Cited by 250 · see citing works
Riley, R. D., Jackson, D., Salanti, G., Burke, D. L., Price, M. J., Kirkham, J. J., & White, I. R. (2017) · BMJ · doi:10.1136/bmj.j3932 · Cited by 244 · see citing works
Apolipoproteins: metabolic role and clinical biochemistry applications
Dominiczak, M. H., & Caslake, M. J. (2011) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011111 · Cited by 238 · cited 1× · see citing works
“A one SD increment of Apo A1 is associated with a reduced hazard ratio of major cardiovascular events [103, 104].”
BackgroundTambalis, K., Panagiotakos, D. B., Kavouras, S. A., & Sidossis, L. S. (2009) · Angiology · doi:10.1177/0003319708324927 · Cited by 224 · cited 1× · see citing works
“An AET intervention ≥ 12 weeks was considered the minimum time to affect lipid profiles [34, 35].”
BackgroundLeMura, L. M., von Duvillard, S. P., Andreacci, J., Klebez, J. M., Chelland, S. A., & Russo, J. (2000) · European Journal of Applied Physiology · doi:10.1007/s004210000234 · Cited by 202 · see citing works
Boekholdt, S. M., Arsenault, B. J., Hovingh, G. K., Mora, S., Pedersen, T. R., LaRosa, J. C., Welch, K. M. A., Amarenco, P., DeMicco, D. A., Tonkin, A. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002670 · Cited by 196 · cited 1× · see citing works
“A one SD increment of Apo A1 is associated with a reduced hazard ratio of major cardiovascular events [103, 104].”
BackgroundSlentz, C. A., Houmard, J. A., Johnson, J. L., Bateman, L. A., Tanner, C. J., McCartney, J. S., Duscha, B. D., & Kraus, W. E. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01314.2006 · Cited by 188 · see citing works
Aerobic exercise and the lipid profile in type 1 diabetic men: a randomized controlled trial
LAAKSONEN, D. E., ATALAY, M., NISKANEN, L. K., MUSTONEN, J., &NA;, C. K., LAKKA, T. A., & UUSITUPA, M. I. J. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200009000-00003 · Cited by 174 · see citing works
The effects of aerobic conditioning and/or caloric restriction in overweight men and women
HAGAN, R. D., UPTON, S. J., Wong, L. G., & Whittam, J. H. (1986) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198602000-00015 · Cited by 165 · see citing works
Kiens, B., JORGENSEN, I., Lewis, S. F., Jensen, G. B., Lithell, H., Vessby, B. O., HOE, S., & Schnohr, P. (1980) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1980.tb00021.x · Cited by 150 · see citing works
Implementation of SI Units for Clinical Laboratory Data
YOUNG, D. S. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-1-114 · Cited by 146 · see citing works
Robinson (2012) · doi:10.1016/j.amjcard.2012.07.007 · Cited by 137 · see citing works
Sunami, Y., Motoyama, M., Kinoshita, F., Mizooka, Y., SUETA, K., Matsunaga, A., Sasaki, J., Tanaka, H., & Shindo, M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90194-4 · Cited by 127 · see citing works
Apolipoproteins as markers and managers of coronary risk
Chan, D. C. (2006) · QJM · doi:10.1093/qjmed/hcl027 · Cited by 117 · see citing works
Lehmann, R., Vokac, A., Niedermann, K., Agosti, K., & Spinas, G. A. (1995) · Diabetologia · doi:10.1007/bf00401764 · Cited by 116 · see citing works
Finucane, F. M., Sharp, S. J., Purslow, L. R., Horton, K., Horton, J., Savage, D., Brage, S., Besson, H., Rolfe, E. D. L., Sleigh, A., et al. (2010) · Diabetologia · doi:10.1007/s00125-009-1641-z · Cited by 115 · see citing works
Implementation of SI Units for Clinical Laboratory Data.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-508_4 · Cited by 113 · see citing works
Effects of aerobic and strength-based training on metabolic health indicators in older adults
Martins, R. A., Veríssimo, M. T., Coelho-e-Silva, M. J., Cumming, S. P., & Teixeira, A. M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-76 · Cited by 107 · see citing works
Moderate or Vigorous Intensity Exercise: Which Is Better for Improving Aerobic Fitness?
Swain, D. P. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.02791.x · Cited by 105 · cited 1× · see citing works
“Studies of either prescribed steady-state or interval AET that employed at least a moderate intensity effort (> 40% VO2MAX) were included, since this intensity is the minimum recommended for sedentary individuals [36, 37].”
Effects of Physical Training on Metabolic Control in Elderly Type 2 Diabetes Mellitus Patients
Ligtenberg, P. C., Hoekstra, J. B. L., Bol, E., Zonderland, M. L., & Erkelens, D. W. (1997) · Clinical Science · doi:10.1042/cs0930127 · Cited by 103 · see citing works
Choi, K. M., Han, K. A., Ahn, H. J., Hwang, S. Y., Hong, H. C., Choi, H. Y., Yang, S. J., Yoo, H. J., Baik, S. H., Choi, D. S., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1951 · Cited by 103 · see citing works
Lipoproteins: When size really matters
German, J. B., Smilowitz, J. T., & Zivkovic, A. M. (2006) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2005.11.006 · Cited by 97 · cited 1× · see citing works
“Apolipoproteins (Apo) A1 and A2 are the largest protein constituent of HDL [6].”
BackgroundNieman, D. C., Brock, D. W., Butterworth, D., Utter, A. C., & Nieman, C. C. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719233 · Cited by 96 · see citing works
Greene, N. P., Martin, S. E., & Crouse, S. F. (2012) · Obesity · doi:10.1038/oby.2012.65 · Cited by 94 · see citing works
The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women
Lindheim, S. R., Notelovitz, M., FELDMAN, E. B., Larsen, S., & Khan, F. Y. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90488-x · Cited by 93 · see citing works
Motoyama, M., Sunami, Y., Kinoshita, F., Irie, T., Sasaki, J., Arakawa, K., Kiyonaga, A., Tanaka, H., & Shindo, M. (1995) · European Journal of Applied Physiology · doi:10.1007/bf00361539 · Cited by 93 · see citing works
Health-related effects of worksite interventions involving physical exercise and reduced workhours
Schwarz, U. V. T., Lindfors, P., & Lundberg, U. (2008) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.1227 · Cited by 88 · see citing works
Ruangthai, R., & Phoemsapthawee, J. (2019) · Journal of Exercise Science & Fitness · doi:10.1016/j.jesf.2019.03.001 · Cited by 85 · cited 1× · see citing works
“Ruangthai and Phoemsapthawee [84] 25 > 55 Mx 2 11 48 24 3 40”
HIIT is not superior to MICT in altering blood lipids: a systematic review and meta-analysis
Wood, G., Murrell, A., van der Touw, T., & Smart, N. (2019) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2019-000647 · Cited by 85 · cited 1× · see citing works
“Our recent comparison of the effects of high-intensity versus moderate-intensity aerobic exercise on lipids suggested that antiatherogenic HDL-C is positively affected by high intensity more than moderate intensity exercise [101].”
BackgroundSelf-citationAldred, H. E., Hardman, A. E., & Taylor, S. (1995) · Metabolism · doi:10.1016/0026-0495(95)90172-8 · Cited by 82 · see citing works
Krustrup, P., Hansen, P. R., Randers, M. B., Nybo, L., Martone, D., Andersen, L. J., Bune, L. T., Junge, A., & Bangsbo, J. (2010) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2010.01110.x · Cited by 79 · see citing works
Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful
Superko, H. R. (2009) · Circulation · doi:10.1161/circulationaha.108.809582 · Cited by 78 · see citing works
Knoepfli-Lenzin, C., Sennhauser, C., Toigo, M., Boutellier, U., Bangsbo, J., Krustrup, P., Junge, A., & Dvořák, J. (2010) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2009.01089.x · Cited by 74 · see citing works
Tully, M. A., Cupples, M., Hart, N. D., McEneny, J., McGlade, K. J., Chan, W.-S., & Young, I. S. (2007) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2006.053058 · Cited by 72 · see citing works
The Impact of Exercise Training on Blood Lipids in Older Adults
Boardley, D., Fahlman, M., Topp, R., Morgan, A. L., & McNevin, N. (2007) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2007.05353.x · Cited by 72 · see citing works
Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol
Su, X., Kong, Y., & Peng, D. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1080-x · Cited by 72 · see citing works
Effects of endurance training on serum lipids
Fikenzer, K., Fikenzer, S., Laufs, U., & Werner, C. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.11.005 · Cited by 67 · cited 16× · see citing works
“We included AET protocols with an intensity (> 40% VO2MAX) at the lower end of the moderate-intensity range; this low-intensity may elicit very small changes in lipids [19], and the inclusion of these protocols may have resulted in understated effect sizes.”
BackgroundMethodResultInfluentialRossi, F. E., Fortaleza, A. C. D. S., Neves, L. M., Buonani, C., Picolo, M. R., Diniz, T. A., Kalva‐Filho, C. A., Papoti, M., Lira, F. S., & Júnior, I. F. F. (2015) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000001020 · Cited by 66 · see citing works
Hinkleman, L. L., & Nieman, D. C. (1993) · PubMed · Cited by 64 · see citing works
Walking program reduces elevated cholesterol in women postmenopause.
Ready, A. E., Drinkwater, D. T., Ducas, J., Fitzpatrick, D., Brereton, D. G., & Oades, S. C. (1995) · PubMed · Cited by 60 · see citing works
Calling, S., Johansson, S.-E., Wolff, M., Sundquist, J., & Sundquist, K. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1228-7 · Cited by 60 · cited 1× · see citing works
“A recent 17-year follow-up study of females concluded the TC/HDL-C ratio was a potent predictor of CVD events [4].”
BackgroundBaker, T. T., Allen, D., Lei, K. Y., & Willcox, K. K. (1986) · Metabolism · doi:10.1016/0026-0495(86)90040-5 · Cited by 58 · see citing works
Physical Activity and Serum Lipids and Lipoproteins in Elderly Women
Nieman, D. C., Warren, B. J., O'Donnell, K. A., Dotson, R. G., Butterworth, D. E., & Henson, D. A. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb06485.x · Cited by 55 · see citing works
Sandhu, P. K., Musaad, S. M. A., Remaley, A. T., Buehler, S. S., Strider, S., Derzon, J. H., Vesper, H. W., Ranne, A., Shaw, C. S., & Christenson, R. H. (2016) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2016.021006 · Cited by 55 · see citing works
Sigal, R. J., Kenny, G. P., Boulé, N. G., Wells, G. A., Prud'homme, D., Fortier, M., Reid, R. D., Tulloch, H., Coyle, D., Phillips, P., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00005 · Cited by 48 · cited 1× · see citing works
“A potential limitation of our work is the use of aggregated RCT data and not individual subject data [113, 114], with the exception of one study [86].”
Ring‐Dimitriou, S., von DUVILLARD, S. P., Paulweber, B., Stadlmann, M., LeMura, L. M., Peak, K., & Mueller, E. (2006) · European Journal of Applied Physiology · doi:10.1007/s00421-006-0347-x · Cited by 45 · see citing works
Wood, G., Taylor, E., Ng, V., Murrell, A., Patil, A., van der Touw, T., Sigal, R., Wolden, M., & Smart, N. (2022) · British Journal of Sports Medicine · doi:10.1136/bjsports-2021-103999 · Cited by 45 · cited 2× · see citing works
“Aerobic exercise training (AET) positively affects dyslipidaemia and MetS [17–20] and lowers CVD risk [21, 22].”
BackgroundResultSelf-citationWirth, A. G., Diehm, C., Hanel, W., WELTE, J., & VOGEL, I. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90120-0 · Cited by 42 · see citing works
Pw, G., Oden, G., Crouse, S. F., Brown, J. A., & Js, G. (1996) · PubMed · Cited by 42 · see citing works
Niederseer, D., Ledl-Kurkowski, E., Kvita, K., et al. (2011) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2011.01341.x · Cited by 40 · see citing works
Suter, E., Marti, B., Tschopp, A., Wanner, H. U., Wenk, C., & Gutzwiller, F. S. (1990) · International Journal of Sports Medicine · doi:10.1055/s-2007-1024832 · Cited by 39 · see citing works
Gahreman, D. E., Heydari, M., Boutcher, Y. N., Freund, J., & Boutcher, S. H. (2016) · Nutrients · doi:10.3390/nu8080510 · Cited by 39 · see citing works
Lipids and disorders of lipoprotein metabolism
Bayly, G. R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-7020-5140-1.00037-7 · Cited by 37 · cited 11× · see citing works
“Apolipoprotein B100 mmol/L was joined with VLDL mmol/L (atherogenic) and analysed.”
BackgroundInfluentialFurukawa, F., Kazuma, K., Kawa, M., Miyashita, M., Niiro, K., Kusukawa, R., & Kojima, M. (2003) · Biological Research For Nursing · doi:10.1177/1099800402239623 · Cited by 34 · see citing works
Jeon, Y. K., Kim, S. S., Kim, J. H., Kim, H. J., Kim, H. J., Park, J. J., Cho, Y. S., Joung, S. H., Kim, J. R., Kim, B. H., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0160 · Cited by 34 · see citing works
Kukkonen-Harjula, K. T., Laukkanen, R. M. T., VUORI, I. M., et al. (1998) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.1998.tb00198.x · Cited by 32 · see citing works
A Comparison of Fitness Training to a Pedometer-Based Walking Program Matched for Total Energy Cost
Bell, G. J., Harber, V. J., Murray, T. C., Courneya, K. S., & Rodgers, W. M. (2010) · Journal of Physical Activity and Health · doi:10.1123/jpah.7.2.203 · Cited by 30 · see citing works
Norwitz, N. G., & Loh, V. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00097 · Cited by 29 · cited 14× · see citing works
“The standard lipid profile (SLP) biomarkers used to evaluate cardiovascular (CVD) risk comprise total cholesterol (TC), triglycerides (TRG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) [1].”
BackgroundInfluentialBrisk Walking and Serum Lipoprotein Variables in Formerly Sedentary Men Aged 42–59 Years
Stensel, D. J., Hardman, A. E., Brooke-Wavell, K. S. F., Vallance, D. T., Jones, P. R. M., Norgan, N. G., & WINDER, A. F. (1993) · Clinical Science · doi:10.1042/cs0850701 · Cited by 28 · see citing works
Hespel, P., Lijnen, P. J., Fagard, R. H., Hoof, R. V., Rosseneu, M., & Amery, A. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90880-0 · Cited by 27 · see citing works
Serum Lipoproteins in Overweight/Obese Postmenopausal Women
Mohanka, M. R., Irwin, M. L., Heckbert, S. R., Yasui, Y., Sorensen, B. E., Chubak, J., Tworoger, S. S., Ulrich, C. M., & McTiernan, A. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000184584.95000.e4 · Cited by 26 · see citing works
Exercise and weight loss effects on cardiovascular risk factors in overweight men
Rosenkilde, M., Rygaard, L., Nordby, P., Nielsen, L. B., & Stallknecht, B. M. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01092.2017 · Cited by 26 · see citing works
Costa, R. R., Pilla, C., Buttelli, A. C. K., Barreto, M. F., Vieiro, P. A., Alberton, C. L., Bracht, C. G., & Kruel, L. F. M. (2018) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.2018.1441485 · Cited by 25 · see citing works
Connolly, L. J., Scott, S., Morencos, C. M., Fulford, J., JONES, A. M., KNAPP, K. M., Krustrup, P., Bailey, S. J., & Bowtell, J. L. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04315-7 · Cited by 23 · see citing works
Gentile, M., Iannuzzi, A., Giallauria, F., D’Andrea, A., Venturini, E., Pacileo, M., Covetti, G., Panico, C., Mattiello, A., Vitale, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051422 · Cited by 21 · see citing works
Little effect of long-term, self-monitored exercise on serum lipid levels in middle-aged women.
Suter, E., & Marti, B. (1992) · PubMed · Cited by 21 · see citing works
Korshøj, M., Ravn, M. H., Holtermann, A., Hansen, Å. M., & Krustrup, P. (2015) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-015-1067-5 · Cited by 18 · see citing works
Schmidt, C., & Bergström, G. (2014) · Angiology · doi:10.1177/0003319713511849 · Cited by 18 · see citing works
(2018) · Europe PMC (PubMed Central) · Cited by 17 · see citing works
Wang, F., Wang, X., Ye, P., Cao, R., Zhang, Y., Qi, Y., & Zhao, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-017-0650-z · Cited by 16 · see citing works
Edwards, M., & Loprinzi, P. (2019) · Journal of Physical Activity and Health · doi:10.1123/jpah.2016-0389 · Cited by 16 · see citing works
Effect of physical exercise on lipid metabolism in the elderly.
Veríssimo, M. T., Aragão, A., Sousa, A. C., Barbosa, B., Ribeiro, H., Costa, D., & Saldanha, M. H. (2002) · PubMed · Cited by 15 · see citing works
Paolillo, F. R., Borghi‐Silva, A., Arena, R. A., Parizotto, N. A., Kurachi, C., & Bagnato, V. S. (2017) · Journal of Cosmetic and Laser Therapy · doi:10.1080/14764172.2017.1326610 · Cited by 13 · see citing works
The Effect of Physical Activity on Serum Lipids, Lipoprotein, and Apolipoproteins
Shearman, J., Micklewright, D. P., Hardcastle, J., Hamlin, M. J., & Draper, N. (2010) · UC Research Repository (University of Canterbury) · doi:10.5628/aehd.v1i2.86 · Cited by 10 · see citing works
Kodama, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.999 · Cited by 5 · see citing works
Quantitative Assays of Plasma Apolipoproteins
Poljak, A., Duncan, M. W., Jayasena, T., & Sachdev, P. S. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0471-7_3 · Cited by 3 · see citing works
High-Density Lipoprotein Metabolism
Brewer, H. B. (2009) · Clinical Lipidology · doi:10.1016/b978-141605469-6.50008-1 · Cited by 3 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Fu R, Vandermeer B, Shamliyan T, O’Neil M, Yazdi F, Fox S et al. Handling Continuous Outcomes in Quantitative Synthesis. In: Methods guide for effectiveness and comparative effectiveness reviews [Internet]. Agency for Healthcare Research and Quality (US); 2008, Rockville (MD). 2013. https://www.ncbi.nlm.nih.gov/books/NBK154408/. Accessed 22 May 2019.
Cited by
Sorted by citations
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · JACC · doi:10.1016/j.jacc.2025.11.016 · Cited by 304 · see citing works
Writing Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001423 · Cited by 122 · see citing works
The Effect of Exercise Training on Blood Lipids: A Systematic Review and Meta-analysis
Smart, N. A., Downes, D., van der Touw, T., Hada, S., Dieberg, G., Pearson, M. J., Wolden, M., King, N., & Goodman, S. P. J. (2025) · Sports Medicine · doi:10.1007/s40279-024-02115-z · Cited by 100 · see citing works
“Previous works were not systematic [14] or included non-randomized trials [13, 15]; limited pooled data analyses have been previously published [16, 17].”
Self-citationMilani, J. G. P. O., Milani, M., Verboven, K., Cipriano, G., & Hansen, D. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1380639 · Cited by 46 · see citing works
ApoB100 and Atherosclerosis: What’s New in the 21st Century?
Kounatidis, D. C., Vallianou, N. G., Poulaki, A., Evangelopoulos, A. A., Panagopoulos, F., Stratigou, T., Geladari, E. V., Karampela, Ι., & Dalamaga, Μ. (2024) · Metabolites · doi:10.3390/metabo14020123 · Cited by 45 · see citing works
“AET beneficially lowered ApoB100 by 2.073 mg/dL, suggesting a potential 4.34% reduction in CHD risk, given that a 9% decrease in CHD risk occurs for every reduction in ApoB100 [112,113].”
BackgroundInfluentialHyperlipidemia Prevention and Management Utilizing Lifestyle Changes
Giles, L. A. (2024) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.13637 · Cited by 36 · see citing works
Chen, Z., Zhou, R., Liu, X., Wang, J., Wang, L., Lv, Y., & Yu, L. (2025) · Life · doi:10.3390/life15020166 · Cited by 32 · see citing works
“Aerobic exercise (AE), as a crucial form of physical activity, is widely acknowledged for its significant impact on enhancing metabolic health and mitigating the risk of CVDs [18,19].”
Short-term HIIT impacts HDL function differently in lean, obese, and diabetic subjects
Zhu, L., An, J., Luu, T. N., Reyna, S. M., Tantiwong, P., Sriwijitkamol, A., Musi, N., & Stafford, J. M. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1423989 · Cited by 12 · see citing works
Li, Z., Qi, Y., Chen, X., Li, J., Zhang, J., Li, P., & Zhou, Z. (2024) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.14764 · Cited by 9 · see citing works
Zoila, F., Filannino, F. M., Panaro, M. A., Sannicandro, I., Cianciulli, A., & Porro, C. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1493827 · Cited by 6 · see citing works
Smart, N. A., Wood, G., Pearson, M. J., Dieberg, G., van der Touw, T., & Kostner, K. (2025) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2025.11.004 · Cited by 6 · see citing works
Self-citationGaskin, J., Li, W. W., van Eijk, L., & Sarnyai, Z. (2025) · Police Practice and Research · doi:10.1080/15614263.2025.2506647 · Cited by 6 · see citing works
“The correlations between different outcomes within the same study were accounted for by assuming a correlation of r = 0.5 (Wampold et al., 1997; White et al., 2019; Wood et al., 2023).”
InfluentialEffect of Exercise Training on Apolipoproteins: Meta-analysis and Trial Sequence Analysis
Downes, D., Goodman, S. P. J., der Touw, T. V., Ahmed, K., Neto, M. G., Wolden, M., & Smart, N. A. (2025) · International Journal of Sports Medicine · doi:10.1055/a-2580-0722 · Cited by 3 · see citing works
Self-citationAssociations between physical activity and CVD-related metabolomic and proteomic biomarkers
Ekblom, Ö. B., Björkbacka, H., Börjesson, M., Ekblom‐Bak, E., Blomberg, A., Caidahl, K., Ehrenborg, E., Engström, G., Engvall, J. E., Erlinge, D., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325720 · Cited by 2 · see citing works
Lang, X., Huang, S., & Xiao, Y. (2025) · Behavioral Sciences · doi:10.3390/bs15080996 · Cited by 3 · see citing works
“…in reducing the risk of chronic diseases and mitigating adverse health outcomes associated with chronic conditions, such as a healthy diet that could significantly improve cardiometabolic profiles and aerobic exercise positively affecting blood lipid (Wood et al., 2023; Yiaslas et al., 2024).”
Zhou, T., Su, S., Yuan, C., Jiang, D., Qiu, Y., Xiao, J., Lu, X., Gu, D., & Liu, F. (2026) · Medicine Plus · doi:10.1016/j.medp.2026.100137 · Cited by 2 · see citing works
Lim, H., Kim, T., Kang, H.-J., & Lee, H. (2024) · Nutrients · doi:10.3390/nu16060813 · Cited by 2 · see citing works
“Apo interacts with phospholipids to help dissolve cholesterol esters and neutral fats and regulates the reactions of lipids and various enzymes [28,29].”
BackgroundZhang, Y., Lee, D. H., Rezende, L. F. M., & Giovannucci, E. L. (2025) · Preventive Medicine · doi:10.1016/j.ypmed.2025.108261 · Cited by 2 · see citing works
Alyafei, A. A., Hussein, A. M., Amdouni, S., et al. (2025) · Cureus · doi:10.7759/cureus.83580 · Cited by 1 · see citing works
“Further confirmation by Wood et al. revealed that engaging in 12 weeks of aerobic exercise led to a 12% reduction in low-density lipoprotein (LDL) cholesterol, a 15% increase in high-density lipoprotein (HDL) cholesterol, and a 10% decrease in triglycerides (TGs) [7].”
Fu, T., Xiao, M., Ding, J., Lu, C., Wang, P., Yang, J., & Zhang, Q. (2024) · Advanced Chinese Medicine · doi:10.1002/acm4.26
Strategies to Overcome Metabolic Syndrome and Related Diseases
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-5556-9
Siebers, M., Bizjak, D. A., & Grau, M. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.11.003
Gražulevičienė, R., Andrušaitytė, S., Dėdelė, A., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1747963
Poteryaeva, O. N., & Федорович, У. И. (2025) · Human Physiology · doi:10.1134/s036211972570077x
“Long-distance running is associated with an increase in total lipoprotein lipase activity by 1.5–2 times [26].”
InfluentialGao, K., Zhou, Y., Zhou, C., Luo, L., Lang, D., & Feng, J. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1810357
“Mechanistically, aerobic exercise enhances lipoprotein lipase activity to promote triglyceride breakdown while improving cholesterol reverse transport, thereby elevating HDL levels and reducing LDL and TC (Wood et al., 2023).”
Li, J., Yuan, J., Wang, F., Zeng, Q., Zhang, Y., & Ma, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1837386
A comparison of multivariate and univariate meta-analysis
Du, H. (2026) · Behavior Research Methods · doi:10.3758/s13428-026-03072-3
“Wood et al. (2023) reported univariate I 2 values ranging from 0% to 26.71% for each individual mean difference outcome.”
InfluentialZeng, J., Wang, H., & Shi, F. (2026) · Metabolites · doi:10.3390/metabo16090683
“Aerobic training also improves apolipoproteins, lipoprotein subfractions, and atherogenic lipid ratios that are not captured by fasting TG alone [48].”
Liu, J., Shi, R., Fu, W., & Ming, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1947147
Soh, C. H., Kent, M., van Loggerenberg, E., Alexopoulos, N., & Lu, S. (2026) · Longevity · doi:10.1080/30653495.2026.2743528
Yan, X., Li, J., & Wang, T. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06151-w
- Authors
- Wood, G., Taylor, E., Ng, V., Murrell, A., Patil, A., van der Touw, T., Wolden, M., Andronicos, N., & Smart, N. A.
- Affiliations
- Curtin University (AU)
- University of New England (AU)
- University of Jamestown (US)
- Corresponding author
- Wood, Gina
- ORCID
- Venue
- Sports Medicine
- Published
- 2023-03-02
- Volume
- 53
- Issue
- 4
- Pages
- 871-886
- ISSN
- 0112-1642 (ISSN-L)
- 1179-2035
- PMC
- PMC10036419
- OpenAlex
- W4322758115
- Semantic Scholar
- 740a79130fe0891341ca5400cc41f8f1ca386ea1
- Cited by
- 31
- References
- 111
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 8
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Sports Medicine (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Physiology › Physical Activity and Health
- Keywords
- aerobic exercise training, lipid biomarkers, apolipoproteins, cardiovascular risk, exercise dose-response, metabolic syndrome, cardiovascular risk prediction, lipid control, sedentary lifestyle
- MeSH terms
- Adult, Cardiovascular Diseases, Humans, Lipids, Lipoproteins, Randomized Controlled Trials as Topic, Resistance Training
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-19.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-19.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review